Review
Open access
Sep 2026
Engineering mRNA‐LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases
ABSTRACT Messenger RNA (mRNA) therapeutics delivered by lipid nanoparticles (LNPs) have advanced from concept to clinic at unprecedented speed, yet their promise for neurodegenerative diseases remains largely untapped. Currently intractable age‐related proteinopathies such as Alzheimer's disease, Parkinson's disease, a...
A. Belaidi, Denzil Furtado, Francesca M. Alves et al.
· Exploration · 1 citation